Literature DB >> 34315405

Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.

Ruoting Lin1, Conor E Fogarty2, Bowei Ma3, Hejie Li2, Guoying Ni1,2,4, Xiaosong Liu1,2,4, Jianwei Yuan5, Tianfang Wang6.   

Abstract

BACKGROUND: Papillary thyroid carcinoma (PTC) is the most common thyroid cancer. While many patients survive, a portion of PTC cases display high aggressiveness and even develop into refractory differentiated thyroid carcinoma. This may be alleviated by developing a novel model to predict the risk of recurrence. Ferroptosis is an iron-dependent form of regulated cell death (RCD) driven by lethal accumulation of lipid peroxides, is regulated by a set of genes and shows a variety of metabolic changes. To elucidate whether ferroptosis occurs in PTC, we analyse the gene expression profiles of the disease and established a new model for the correlation.
METHODS: The thyroid carcinoma (THCA) datasets were downloaded from The Cancer Genome Atlas (TCGA), UCSC Xena and MisgDB, and included 502 tumour samples and 56 normal samples. A total of 60 ferroptosis related genes were summarised from MisgDB database. Gene set enrichment analysis (GSEA) and Gene set variation analysis (GSVA) were used to analyse pathways potentially involving PTC subtypes. Single sample GSEA (ssGSEA) algorithm was used to analyse the proportion of 28 types of immune cells in the tumour immune infiltration microenvironment in THCA and the hclust algorithm was used to conduct immune typing according to the proportion of immune cells. Spearman correlation analysis was performed on the ferroptosis gene expression and the correlation between immune infiltrating cells proportion. We established the WGCNA to identify genes modules that are highly correlated with the microenvironment of immune invasion. DEseq2 algorithm was further used for differential analysis of sequencing data to analyse the functions and pathways potentially involving hub genes. GO and KEGG enrichment analysis was performed using Clusterprofiler to explore the clinical efficacy of hub genes. Univariate Cox analysis was performed for hub genes combined with clinical prognostic data, and the results was included for lasso regression and constructed the risk regression model. ROC curve and survival curve were used for evaluating the model. Univariate Cox analysis and multivariate Cox analysis were performed in combination with the clinical data of THCA and the risk score value, the clinical efficacy of the model was further evaluated.
RESULTS: We identify two subtypes in PTC based on the expression of ferroptosis related genes, with the proportion of cluster 1 significantly higher than cluster 2 in ferroptosis signature genes that are positively associated. The mutations of Braf and Nras are detected as the major mutations of cluster 1 and 2, respectively. Subsequent analyses of TME immune cells infiltration indicated cluster 1 is remarkably richer than cluster 2. The risk score of THCA is in good performance evaluated by ROC curve and survival curve, in conjunction with univariate Cox analysis and multivariate Cox analysis results based on the clinical data shows that the risk score of the proposed model could be used as an independent prognostic indicator to predict the prognosis of patients with papillary thyroid cancer.
CONCLUSIONS: Our study finds seven crucial genes, including Ac008063.2, Apoe, Bcl3, Acap3, Alox5ap, Atxn2l and B2m, and regulation of apoptosis by parathyroid hormone-related proteins significantly associated with ferroptosis and immune cells in PTC, and we construct the risk score model which can be used as an independent prognostic index to predict the prognosis of patients with PTC.
© 2021. The Author(s).

Entities:  

Keywords:  Ferroptosis genes; Immune-related genes; Prognostic model; Thyroid papillary carcinoma; Tumour microenvironment

Year:  2021        PMID: 34315405     DOI: 10.1186/s12864-021-07895-6

Source DB:  PubMed          Journal:  BMC Genomics        ISSN: 1471-2164            Impact factor:   3.969


  65 in total

1.  Thyroid cancer: zealous imaging has increased detection and treatment of low risk tumours.

Authors:  Juan P Brito; John C Morris; Victor M Montori
Journal:  BMJ       Date:  2013-08-27

2.  Diabetes. 1.

Authors:  A R Holder
Journal:  JAMA       Date:  1973-01-22       Impact factor: 56.272

3.  FMO1 gene expression independently predicts favorable recurrence-free survival of classical papillary thyroid cancer.

Authors:  Jing Luo; Bowei Zhang; Likun Cui; Tong Liu; Yi Gu
Journal:  Future Oncol       Date:  2019-02-13       Impact factor: 3.404

4.  Histopathologic characterization of radioactive iodine-refractory fluorodeoxyglucose-positron emission tomography-positive thyroid carcinoma.

Authors:  Michael Rivera; Ronald A Ghossein; Heiko Schoder; Daniel Gomez; Steven M Larson; R Michael Tuttle
Journal:  Cancer       Date:  2008-07-01       Impact factor: 6.860

5.  The epidemic of thyroid cancer in the United States: the role of endocrinologists and ultrasounds.

Authors:  Robert Udelsman; Yawei Zhang
Journal:  Thyroid       Date:  2013-10-29       Impact factor: 6.568

Review 6.  Thyroid cancer.

Authors:  Tobias Carling; Robert Udelsman
Journal:  Annu Rev Med       Date:  2013-11-20       Impact factor: 13.739

Review 7.  Pediatric papillary thyroid cancer: current management challenges.

Authors:  Frederik A Verburg; Hanneke M Van Santen; Markus Luster
Journal:  Onco Targets Ther       Date:  2016-12-28       Impact factor: 4.147

8.  Global Burden of Thyroid Cancer From 1990 to 2017.

Authors:  YuJiao Deng; HongTao Li; Meng Wang; Na Li; Tian Tian; Ying Wu; Peng Xu; Si Yang; Zhen Zhai; LingHui Zhou; Qian Hao; DingLi Song; TianBo Jin; Jun Lyu; ZhiJun Dai
Journal:  JAMA Netw Open       Date:  2020-06-01

9.  Impact of Overweight and Obesity on US Papillary Thyroid Cancer Incidence Trends (1995-2015).

Authors:  Cari M Kitahara; Ruth M Pfeiffer; Julie A Sosa; Meredith S Shiels
Journal:  J Natl Cancer Inst       Date:  2020-08-01       Impact factor: 13.506

View more
  11 in total

1.  Identification and Validation of a Prognostic Signature for Thyroid Cancer Based on Ferroptosis-Related Genes.

Authors:  Yue Wang; Jing Yang; Shitu Chen; Weibin Wang; Lisong Teng
Journal:  Genes (Basel)       Date:  2022-06-01       Impact factor: 4.141

2.  Ferroptosis-Related APOE, BCL3 and ALOX5AP Gene Polymorphisms are Associated with the Risk of Thyroid Cancer.

Authors:  Zhifu Xiao; Haixia Zhao
Journal:  Pharmgenomics Pers Med       Date:  2022-02-25

3.  ASF1B is a Promising Prognostic Biomarker and Correlates With Immunotherapy Efficacy in Hepatocellular Carcinoma.

Authors:  Shirong Zhang; Longwen Xu; Jinteng Feng; Deli Tan; Yue Zhu; Jia Hou; Wenyuan Li; Kejia Lv; Wenjuan Wang; Lili Jiang; Min Jiao; Hui Guo
Journal:  Front Genet       Date:  2022-03-10       Impact factor: 4.599

4.  A Potential Nine-lncRNAs Signature Identification and Nomogram Diagnostic Model Establishment for Papillary Thyroid Cancer.

Authors:  Jin-Ming Yao; Jun-Yu Zhao; Fang-Fang Lv; Xue-Bo Yang; Huan-Jun Wang
Journal:  Pathol Oncol Res       Date:  2022-02-23       Impact factor: 3.201

5.  Identification of HMOX1 as a Critical Ferroptosis-Related Gene in Atherosclerosis.

Authors:  Daiqian Wu; Qian Hu; Yuqing Wang; Mengying Jin; Ziqi Tao; Jing Wan
Journal:  Front Cardiovasc Med       Date:  2022-04-14

6.  The Role of ApoE Serum Levels and ApoE Gene Polymorphisms in Patients with Laryngeal Squamous Cell Carcinoma.

Authors:  Rasa Liutkeviciene; Justina Auzelyte; Vykintas Liutkevicius; Alvita Vilkeviciute; Greta Gedvilaite; Paulius Vaiciulis; Virgilijus Uloza
Journal:  Biomolecules       Date:  2022-07-22

7.  The prognostic value of an immune-related gene signature and infiltrating tumor immune cells based on bioinformatics analysis in primary esophageal cancer.

Authors:  Hailei Du; Shuai Pang; Yong Li; Lianggang Zhu; Junbiao Hang; Ling Chen
Journal:  J Gastrointest Oncol       Date:  2022-08

8.  Identification of immune-related ferroptosis prognostic marker and in-depth bioinformatics exploration of multi-omics mechanisms in thyroid cancer.

Authors:  Xin Fan; Fei Xie; Lingling Zhang; Chang Tong; Zhiyuan Zhang
Journal:  Front Mol Biosci       Date:  2022-08-17

9.  Construction of a tumor immune infiltration macrophage signature for predicting prognosis and immunotherapy response in liver cancer.

Authors:  Anmin Huang; Bei Lv; Yunjie Zhang; Junhui Yang; Jie Li; Chengjun Li; Zhijie Yu; Jinglin Xia
Journal:  Front Mol Biosci       Date:  2022-09-02

10.  Comprehensive analysis of the relationship between the ferroptosis and tumor-infiltrating immune cells, mutation, and immunotherapy in breast cancer.

Authors:  Zhixian He; Zuoyuan Zhou; Feiran Wang; Ling Gai; Yeqing Huang; Xiang Zhong; Jing Li; Ling Zuo; Nannan Zhang; Sujie Ni
Journal:  Ann Transl Med       Date:  2022-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.